Meridian gets FDA clearance for new neonatal saliva CMV test
Meridian Bioscience announced it has received FDA clearance for its new Alethia™ CMV Molecular Amplification Test (formerly, the illumigene brand). This assay is designed to specifically detect congenital Cytomegalovirus infection in newborns from an easy-to-collect saliva sample. December 06, 2018